Biotech Investment Solutions
Unlock the true potential of your biotech investments with our “Scientific Due Diligence for Biotech Investments” service. We specialize in bridging the gap between financial analysis and the complex world of biotech innovation, helping you make informed decisions that maximize returns.
With over 25 years of experience in biotechnology—including expertise in laboratory work, product development, data analysis, and bioinformatics—we deliver detailed evaluations of scientific validity, innovation potential, and associated risks.
Our unique algorithm objectively assesses investment risks, providing you with a clear, actionable risk score to guide your biotech investments.
What the Service Includes
Thorough Review of R&D
Risk Assessment
Evaluation of Technical Feasibility
Comparative Analysis
Customized Reports
Get in Touch with Us Who Can Benefit ?
Individual Investors
Venture Capital Firms
Private Equity Groups
Corporate Investors
Our Unique Risk Assessment Methodology
We have developed a unique scoring system designed to evaluate the potential risks of biotech investments. Our method is entirely data-driven and provides a clear, objective picture of a company’s scientific and technical strengths, along with its market potential.
Companies are assigned a risk score within one of the following ranges, offering a transparent view of their overall risk profile:
- 600-800: Low Risk – Scientifically robust, strong technical feasibility, and minimal regulatory challenges.
- 400-599: Moderate Risk – Well-positioned but may encounter challenges in certain areas.
- 200-399: High Risk – Multiple concerns could pose significant risks to the company’s success.
- Below 200: Very High Risk – Critical issues in several categories, indicating a highly risky profile.
This scoring system helps investors make informed decisions by providing a comprehensive evaluation of a company’s potential.
PACKAGES
Frequently Asked Questions
We recommend starting with a consultation to assess your specific needs and determine the best package for your investment.
The duration varies depending on the scope and complexity of the project. A basic review might take 1-2 weeks, while a comprehensive analysis could take 4-6 weeks. We will provide a timeline during our initial consultation.
Absolutely! We offer flexible packages that can be tailored to your specific requirements. During the consultation, we can discuss your needs and create a customized plan that fits your goals.
You will receive detailed, customized reports that include a thorough analysis of the scientific research, risk assessments, and comparative analysis. These reports are designed to provide you with actionable insights for your investment decisions.
If you require services beyond what’s listed in our packages, we can accommodate those needs. Please discuss them during the consultation, and we’ll incorporate them into a custom package.
We take confidentiality very seriously. All client information is handled with the utmost discretion, and we are happy to sign a non-disclosure agreement (NDA) before any work begins.
If the project scope changes, we will discuss the implications with you and adjust the pricing and timeline accordingly. We ensure that you are informed and agree to any changes before proceeding.
We maintain regular communication with our clients throughout the project. You will receive progress updates at agreed-upon intervals, and we are always available for meetings or discussions as needed.
Payment can be made on an hourly basis or as a flat fee for the selected package. A deposit is typically required to begin the project, with the remaining balance due upon completion. We accept various payment methods, which will be discussed during the initial consultation.
We use a proprietary scoring system that evaluates key scientific, technical, and market factors to determine the risk profile of each company. While we can’t disclose the exact method, the scores are based on an objective analysis developed from years of industry experience. The result is a reliable risk score that helps investors understand a company’s strengths and weaknesses.
